Bio-IT World August 6, 2020
We’ve learned so much living through these unprecedented times. One lesson is the need to mobilize quickly, provide effective testing and contact tracing, and accelerate the development of therapies and vaccines to protect the global community. The issue is not simply one of speed; it’s more complex than that. We must also enable smarter development cycles with innovative approaches that provide the most expeditious, cost-effective, and, ultimately, safest path forward.
That can only be done through the power of data: the defining currency in drug discovery and clinical development. We need to be able to leverage more of it, faster, and more completely than ever before to shave time off the drug discovery and development time frame.
Artificial intelligence (AI)...